| abstract |
PPARĪ± activators, pharmaceutical compositions containing such compounds, and certain other cellular lipids such as LDL-cholesterol and triglycerides that increase certain cellular lipid levels including high density lipoprotein-cholesterol This for the treatment of diseases, such as atherosclerosis and cardiovascular disease, that lower levels and thereby exacerbate by lowering HDL cholesterol levels and / or increasing LDL-cholesterol and triglyceride levels in mammals, including humans Use of such compounds. [Chemical 1] |